{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:20:06Z","timestamp":1788884406678,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018571","name":"Specific Research Project of Guangxi for Research Bases and Talents","doi-asserted-by":"publisher","award":["Guike AD19259004"],"award-info":[{"award-number":["Guike AD19259004"]}],"id":[{"id":"10.13039\/501100018571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["Guike AB25069107"],"award-info":[{"award-number":["Guike AB25069107"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00204-025-04097-x","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T08:57:30Z","timestamp":1750323450000},"page":"4145-4158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterizing the in vitro metabolic features of seven \u03b1-pyrrolidinophenone-derived synthetic cathinone-type new psychoactive substances"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-7817","authenticated-orcid":false,"given":"Xuan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"3","key":"4097_CR1","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jep.2010.07.001","volume":"132","author":"A Al-Motarreb","year":"2010","unstructured":"Al-Motarreb A, Al-Habori M, Broadley KJ (2010) Khat chewing, cardiovascular diseases and other internal medical problems: the current situation and directions for future research. J Ethnopharmacol 132(3):540\u2013548. https:\/\/doi.org\/10.1016\/j.jep.2010.07.001","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"4097_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.2042-7158.1986.tb04571.x","volume":"38","author":"R Brenneisen","year":"2011","unstructured":"Brenneisen R, Geissh\u00fcsler S, Schorno X (2011) Metabolism of cathinone to (\u2212)-norephedrine and (\u2212)-norpseudoephedrine. J Pharm Pharmacol 38(4):298\u2013300. https:\/\/doi.org\/10.1111\/j.2042-7158.1986.tb04571.x","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"4097_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/ijms22010230","volume":"22","author":"J Carlier","year":"2021","unstructured":"Carlier J, Diao X, Giorgetti R et al (2021) Pyrrolidinyl synthetic cathinones \u03b1-PHP and 4F-\u03b1-PVP metabolite profiling using human hepatocyte incubations. Int J Mol Sci 22(1):230. https:\/\/doi.org\/10.3390\/ijms22010230","journal-title":"Int J Mol Sci"},{"key":"4097_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123162","volume":"1193","author":"J Carlier","year":"2022","unstructured":"Carlier J, Berardinelli D, Montanari E et al (2022) 3F-\u03b1-pyrrolydinovalerophenone (3F-\u03b1-PVP) in vitro human metabolism: multiple in silico predictions to assist in LC-HRMS\/MS analysis and targeted\/untargeted data mining. J Chromatogr B 1193:123162. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123162","journal-title":"J Chromatogr B"},{"issue":"4","key":"4097_CR5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0091-3057(97)00323-7","volume":"58","author":"TA Dal Cason","year":"1997","unstructured":"Dal Cason TA, Young R, Glennon RA (1997) Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav 58(4):1109\u20131116. https:\/\/doi.org\/10.1016\/S0091-3057(97)00323-7","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"4097_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1208\/s12248-024-01012-7","volume":"27","author":"A Di Trana","year":"2025","unstructured":"Di Trana A, La Maida N, de la Rosa G et al (2025) Early and mid-term disposition of \u03b1-PVP and its unknown metabolites in urine and oral fluid through a multi-analytical hyphenated approach following a single non-controlled administration to healthy volunteers. AAPS J 27(1):25. https:\/\/doi.org\/10.1208\/s12248-024-01012-7","journal-title":"AAPS J"},{"issue":"1","key":"4097_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11419-015-0287-4","volume":"34","author":"KN Ellefsen","year":"2016","unstructured":"Ellefsen KN, Wohlfarth A, Swortwood MJ et al (2016) 4-Methoxy-\u03b1-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry. Forensic Toxicol 34(1):61\u201375. https:\/\/doi.org\/10.1007\/s11419-015-0287-4","journal-title":"Forensic Toxicol"},{"key":"4097_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainresbull.2016.04.011","volume":"126","author":"RA Glennon","year":"2016","unstructured":"Glennon RA, Young R (2016) Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and \u03b1-pyrrolidinovalerophenone (\u03b1-PVP). Brain Res Bull 126:111\u2013126. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.04.011","journal-title":"Brain Res Bull"},{"issue":"7","key":"4097_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/10408444.2019.1679087","volume":"49","author":"JL Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves JL, Alves VL, Aguiar J et al (2019) Synthetic cathinones: an evolving class of new psychoactive substances. Crit Rev 49(7):549\u2013566. https:\/\/doi.org\/10.1080\/10408444.2019.1679087","journal-title":"Crit Rev"},{"key":"4097_CR10","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/j.forsciint.2015.12.020","volume":"259","author":"M Grapp","year":"2016","unstructured":"Grapp M, Sauer C, Vidal C et al (2016) GC\u2013MS analysis of the designer drug \u03b1-pyrrolidinovalerophenone and its metabolites in urine and blood in an acute poisoning case. Forensic Sci Int 259:e14\u2013e19. https:\/\/doi.org\/10.1016\/j.forsciint.2015.12.020","journal-title":"Forensic Sci Int"},{"issue":"9","key":"4097_CR11","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/dta.2869","volume":"12","author":"M Grapp","year":"2020","unstructured":"Grapp M, Kaufmann C, Schwelm HM et al (2020) Intoxication cases associated with the novel designer drug 3\u2032,4\u2032-methylenedioxy-\u03b1-pyrrolidinohexanophenone and studies on its human metabolism using high-resolution mass spectrometry. Drug Test Anal 12(9):1320\u20131335. https:\/\/doi.org\/10.1002\/dta.2869","journal-title":"Drug Test Anal"},{"issue":"4","key":"4097_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jbt.20174","volume":"21","author":"FP Guengerich","year":"2007","unstructured":"Guengerich FP (2007) Mechanisms of cytochrome P450 substrate oxidation: MiniReview. J Biochem Mol Toxicol 21(4):163\u2013168. https:\/\/doi.org\/10.1002\/jbt.20174","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"4097_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/ja01280a022","volume":"59","author":"LP Hammett","year":"1937","unstructured":"Hammett LP (1937) The effect of structure upon the reactions of organic compounds. Benzene derivatives. J Am Chem Soc 59(1):96\u2013103. https:\/\/doi.org\/10.1021\/ja01280a022","journal-title":"J Am Chem Soc"},{"issue":"2","key":"4097_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1021\/cr00002a004","volume":"91","author":"C Hansch","year":"1991","unstructured":"Hansch C, Leo A, Taft RW (1991) A survey of Hammett substituent constants and resonance and field parameters. Chem Rev 91(2):165\u2013195. https:\/\/doi.org\/10.1021\/cr00002a004","journal-title":"Chem Rev"},{"issue":"2","key":"4097_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/acs.oprd.1c00189","volume":"26","author":"L He","year":"2022","unstructured":"He L, Ye W, Xie Y et al (2022) Efficient biocatalytic synthesis of (R)-2-chloro-1-(3,4-difluorophenyl)ethanol by the short-chain dehydrogenase PpKR8 from Paraburkholderia phymatum STM815. Organ Process Res Dev 26(2):278\u2013287. https:\/\/doi.org\/10.1021\/acs.oprd.1c00189","journal-title":"Organ Process Res Dev"},{"issue":"1","key":"4097_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00216-015-9088-1","volume":"408","author":"M Ib\u00e1\u00f1ez","year":"2016","unstructured":"Ib\u00e1\u00f1ez M, Pozo \u00d3J, Sancho JV et al (2016) Analytical strategy to investigate 3,4-methylenedioxypyrovalerone (MDPV) metabolites in consumers\u2019 urine by high-resolution mass spectrometry. Anal Bioanal Chem 408(1):151\u2013164. https:\/\/doi.org\/10.1007\/s00216-015-9088-1","journal-title":"Anal Bioanal Chem"},{"key":"4097_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2020.110214","volume":"310","author":"A Ishii","year":"2020","unstructured":"Ishii A, Kusakabe K, Kato N et al (2020) Studies on the phase I metabolites of the new designer drug 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidine-1-yl)butan-1-one (5-PPDI) in human urine. Forensic Sci Int 310:110214. https:\/\/doi.org\/10.1016\/j.forsciint.2020.110214","journal-title":"Forensic Sci Int"},{"issue":"22","key":"4097_CR18","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1021\/acs.jpca.7b02630","volume":"121","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Zhu X, Xing X (2017) Electrochemical oxidation of phenolic compounds at boron-doped diamond anodes: structure\u2013reactivity relationships. J Phys Chem A 121(22):4326\u20134333. https:\/\/doi.org\/10.1021\/acs.jpca.7b02630","journal-title":"J Phys Chem A"},{"issue":"3","key":"4097_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0163-7258(90)90057-9","volume":"48","author":"P Kalix","year":"1990","unstructured":"Kalix P (1990) Pharmacological properties of the stimulant khat. Pharmacol Ther 48(3):397\u2013416. https:\/\/doi.org\/10.1016\/0163-7258(90)90057-9","journal-title":"Pharmacol Ther"},{"issue":"2","key":"4097_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/bf00579708","volume":"18","author":"P Kalix","year":"1996","unstructured":"Kalix P (1996) Catha edulis, a plant that has amphetamine effects. Pharm World Sci 18(2):69\u201373. https:\/\/doi.org\/10.1007\/bf00579708","journal-title":"Pharm World Sci"},{"issue":"10","key":"4097_CR21","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/dta.2891","volume":"12","author":"P Kavanagh","year":"2020","unstructured":"Kavanagh P, Gofenberg M, Shevyrin V et al (2020) Tentative identification of the phase I and II metabolites of two synthetic cathinones, MDPHP and \u03b1-PBP, in human urine. Drug Test Anal 12(10):1442\u20131451. https:\/\/doi.org\/10.1002\/dta.2891","journal-title":"Drug Test Anal"},{"key":"4097_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jpba.2016.08.025","volume":"131","author":"IS Kim","year":"2016","unstructured":"Kim IS, Rehman SU, Choi MS et al (2016) Characterization of in vitro metabolites of methylenedioxypyrovalerone (MDPV): an N-oxide metabolite formation mediated by flavin monooxygenase. J Pharm Biomed Anal 131:160\u2013166. https:\/\/doi.org\/10.1016\/j.jpba.2016.08.025","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"4097_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1021\/acschemneuro.8b00525","volume":"10","author":"TO Kolesnikova","year":"2019","unstructured":"Kolesnikova TO, Khatsko SL, Demin KA et al (2019) DARK classics in chemical neuroscience: \u03b1-pyrrolidinovalerophenone (\u201cFlakka\u201d). ACS Chem Neurosci 10(1):168\u2013174. https:\/\/doi.org\/10.1021\/acschemneuro.8b00525","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"4097_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1063\/5.0216272","volume":"161","author":"T Lu","year":"2024","unstructured":"Lu T (2024) A comprehensive electron wavefunction analysis toolbox for chemists, Multiwfn. J Chem Phys 161(8):42. https:\/\/doi.org\/10.1063\/5.0216272","journal-title":"J Chem Phys"},{"issue":"5","key":"4097_CR25","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcc.22885","volume":"33","author":"T Lu","year":"2012","unstructured":"Lu T, Chen F (2012a) Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem 33(5):580\u2013592. https:\/\/doi.org\/10.1002\/jcc.22885","journal-title":"J Comput Chem"},{"key":"4097_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jmgm.2012.07.004","volume":"38","author":"T Lu","year":"2012","unstructured":"Lu T, Chen F (2012b) Quantitative analysis of molecular surface based on improved Marching Tetrahedra algorithm. J Mol Graph Model 38:314\u2013323. https:\/\/doi.org\/10.1016\/j.jmgm.2012.07.004","journal-title":"J Mol Graph Model"},{"issue":"3","key":"4097_CR27","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00204-024-03937-6","volume":"99","author":"X Luo","year":"2025","unstructured":"Luo X, Chen Q, Huang K et al (2025) In vitro metabolism of seven arolyl-derived fentanyl-type new psychoactive substances. Arch Toxicol 99(3):1059\u20131072. https:\/\/doi.org\/10.1007\/s00204-024-03937-6","journal-title":"Arch Toxicol"},{"issue":"7","key":"4097_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/dta.2355","volume":"10","author":"SK Manier","year":"2018","unstructured":"Manier SK, Richter LHJ, Sch\u00e4per J et al (2018) Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse. Drug Test Anal 10(7):1119\u20131130. https:\/\/doi.org\/10.1002\/dta.2355","journal-title":"Drug Test Anal"},{"issue":"6","key":"4097_CR29","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s00204-020-02742-1","volume":"94","author":"SK Manier","year":"2020","unstructured":"Manier SK, Wagmann L, Flockerzi V et al (2020) Toxicometabolomics of the new psychoactive substances \u03b1-PBP and \u03b1-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts. Arch Toxicol 94(6):2047\u20132059. https:\/\/doi.org\/10.1007\/s00204-020-02742-1","journal-title":"Arch Toxicol"},{"issue":"5","key":"4097_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tetasy.2008.12.035","volume":"20","author":"T Matsuda","year":"2009","unstructured":"Matsuda T, Yamanaka R, Nakamura K (2009) Recent progress in biocatalysis for asymmetric oxidation and reduction. Tetrahedron Asymmetry 20(5):513\u2013557. https:\/\/doi.org\/10.1016\/j.tetasy.2008.12.035","journal-title":"Tetrahedron Asymmetry"},{"issue":"2","key":"4097_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s11419-018-0428-7","volume":"36","author":"S Matsuta","year":"2018","unstructured":"Matsuta S, Shima N, Kakehashi H et al (2018) Metabolism of \u03b1-PHP and \u03b1-PHPP in humans and the effects of alkyl chain lengths on the metabolism of \u03b1-pyrrolidinophenone-type designer drugs. Forensic Toxicol 36(2):486\u2013497. https:\/\/doi.org\/10.1007\/s11419-018-0428-7","journal-title":"Forensic Toxicol"},{"key":"4097_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.18433\/jpps31832","volume":"24","author":"S McClenahan","year":"2021","unstructured":"McClenahan S, Gunnell M, Owens M (2021) Pharmacokinetics of \u03b1-pyrrolidinovalerophenone in male rats with and without vaccination with an \u03b1-pyrrolidinovalerophenone vaccine. J Pharm Pharm Sci 24:267\u2013276. https:\/\/doi.org\/10.18433\/jpps31832","journal-title":"J Pharm Pharm Sci"},{"key":"4097_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.forsciint.2018.02.017","volume":"286","author":"S Mesih\u00e4\u00e4","year":"2018","unstructured":"Mesih\u00e4\u00e4 S, Rasanen I, Ojanper\u00e4 I (2018) Quantitative estimation of \u03b1-PVP metabolites in urine by GC-APCI-QTOFMS with nitrogen chemiluminescence detection based on parent drug calibration. Forensic Toxicol 286:12\u201317. https:\/\/doi.org\/10.1016\/j.forsciint.2018.02.017","journal-title":"Forensic Toxicol"},{"issue":"12","key":"4097_CR34","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/jms.1859","volume":"45","author":"MR Meyer","year":"2010","unstructured":"Meyer MR, Du P, Schuster F et al (2010) Studies on the metabolism of the \u03b1-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC\u2013MS and LC\u2013high-resolution MS and its detectability in urine by GC\u2013MS. J Mass Spectrom 45(12):1426\u20131442. https:\/\/doi.org\/10.1002\/jms.1859","journal-title":"J Mass Spectrom"},{"issue":"19","key":"4097_CR35","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1007\/s00216-015-8763-6","volume":"407","author":"N Negreira","year":"2015","unstructured":"Negreira N, Erratico C, Kosjek T et al (2015) In vitro phase I and phase II metabolism of \u03b1-pyrrolidinovalerophenone (\u03b1-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol. Anal Bioanal Chem 407(19):5803\u20135816. https:\/\/doi.org\/10.1007\/s00216-015-8763-6","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"4097_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/03602532.2018.1448867","volume":"50","author":"L N\u00f3brega","year":"2018","unstructured":"N\u00f3brega L, Dinis-Oliveira RJ (2018) The synthetic cathinone \u03b1-pyrrolidinovalerophenone (\u03b1-PVP): pharmacokinetic and pharmacodynamic clinical and forensic aspects. Drug Metab Rev 50(2):125\u2013139. https:\/\/doi.org\/10.1080\/03602532.2018.1448867","journal-title":"Drug Metab Rev"},{"key":"4097_CR37","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.forsciint.2016.06.034","volume":"266","author":"JE Nycz","year":"2016","unstructured":"Nycz JE, Pazdziorek T, Malecki G et al (2016) Identification and derivatization of selected cathinones by spectroscopic studies. Forensic Sci Int 266:416\u2013426. https:\/\/doi.org\/10.1016\/j.forsciint.2016.06.034","journal-title":"Forensic Sci Int"},{"issue":"15","key":"4097_CR38","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1021\/jp014039h","volume":"106","author":"J Ol\u00e1h","year":"2002","unstructured":"Ol\u00e1h J, Van Alsenoy C, Sannigrahi AB (2002) Condensed Fukui functions derived from stockholder charges: assessment of their performance as local reactivity descriptors. J Phys Chem A 106(15):3885\u20133890. https:\/\/doi.org\/10.1021\/jp014039h","journal-title":"J Phys Chem A"},{"issue":"3","key":"4097_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00204-022-03427-7","volume":"97","author":"R Pelletier","year":"2023","unstructured":"Pelletier R, Le Dar\u00e9 B, Ferron P-J et al (2023) Use of innovative, cross-disciplinary in vitro, in silico and in vivo approaches to characterize the metabolism of chloro-alpha-pyrrolidinovalerophenone (4-Cl-PVP). Arch Toxicol 97(3):671\u2013683. https:\/\/doi.org\/10.1007\/s00204-022-03427-7","journal-title":"Arch Toxicol"},{"issue":"4","key":"4097_CR40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/jcm11041004","volume":"11","author":"L Poyatos","year":"2022","unstructured":"Poyatos L, Torres A, Papaseit E et al (2022) Abuse potential of cathinones in humans: a systematic review. J Clin Med 11(4):1004. https:\/\/doi.org\/10.3390\/jcm11041004","journal-title":"J Clin Med"},{"issue":"6","key":"4097_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/cphc.202001053","volume":"22","author":"F Sessa","year":"2021","unstructured":"Sessa F, Olsson M, S\u00f6derberg F et al (2021) Experimental quantum chemistry: a Hammett-inspired fingerprinting of substituent effects. ChemPhysChem 22(6):569\u2013576. https:\/\/doi.org\/10.1002\/cphc.202001053","journal-title":"ChemPhysChem"},{"issue":"1","key":"4097_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11419-013-0202-9","volume":"32","author":"N Shima","year":"2014","unstructured":"Shima N, Katagi M, Kamata H et al (2014) Metabolism of the newly encountered designer drug \u03b1-pyrrolidinovalerophenone in humans: identification and quantitation of urinary metabolites. Forensic Toxicol 32(1):59\u201367. https:\/\/doi.org\/10.1007\/s11419-013-0202-9","journal-title":"Forensic Toxicol"},{"issue":"2","key":"4097_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11419-015-0274-9","volume":"33","author":"N Shima","year":"2015","unstructured":"Shima N, Kakehashi H, Matsuta S et al (2015) Urinary excretion and metabolism of the \u03b1-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans. Forensic Toxicol 33(2):279\u2013294. https:\/\/doi.org\/10.1007\/s11419-015-0274-9","journal-title":"Forensic Toxicol"},{"issue":"2","key":"4097_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/toxins14020071","volume":"14","author":"B Silva","year":"2022","unstructured":"Silva B, Soares J, Rocha-Pereira C et al (2022) Khat, a cultural chewing drug: a toxicokinetic and toxicodynamic summary. Toxins 14(2):71\u201382. https:\/\/doi.org\/10.3390\/toxins14020071","journal-title":"Toxins"},{"issue":"9","key":"4097_CR45","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1007\/s00204-021-03083-3","volume":"95","author":"J Soares","year":"2021","unstructured":"Soares J, Costa VM, de Lourdes Bastos M et al (2021) An updated review on synthetic cathinones. Arch Toxicol 95(9):2895\u20132940. https:\/\/doi.org\/10.1007\/s00204-021-03083-3","journal-title":"Arch Toxicol"},{"issue":"18","key":"4097_CR46","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1007\/s00216-016-9599-4","volume":"408","author":"MJ Swortwood","year":"2016","unstructured":"Swortwood MJ, Ellefsen KN, Wohlfarth A et al (2016) First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry. Anal Bioanal Chem 408(18):4845\u20134856. https:\/\/doi.org\/10.1007\/s00216-016-9599-4","journal-title":"Anal Bioanal Chem"},{"issue":"21","key":"4097_CR47","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1007\/s00216-013-7137-1","volume":"405","author":"E Tyrkk\u00f6","year":"2013","unstructured":"Tyrkk\u00f6 E, Pelander A, Ketola RA et al (2013) In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography\/quadrupole-time-of-flight mass spectrometry. Anal Bioanal Chem 405(21):6697\u20136709. https:\/\/doi.org\/10.1007\/s00216-013-7137-1","journal-title":"Anal Bioanal Chem"},{"key":"4097_CR48","unstructured":"UNODC (2013) World Drug Report 2013 United Nations Office on Drugs and Crime. https:\/\/www.unodc.org\/documents\/lpo-brazil\/\/noticias\/2013\/03\/2013-03-15_NPS_2013_SMART.pdf. Accessed 12 March 2025"},{"key":"4097_CR49","unstructured":"UNODC (2025a) NPS Substance Groups United Nations Office on Drugs and Crime. https:\/\/www.unodc.org\/LSS\/SubstanceGroup\/GroupsDashboard?testType=NPS. Accessed 12 March 2025"},{"key":"4097_CR50","unstructured":"UNODC (2025b) UNODC Early Warning Advisory on NPS\u2014Summary Dashboard United Nations Office on Drugs and Crime. https:\/\/www.unodc.org\/LSS\/Page\/NPS\/DataVisualisations. Accessed 12 March 2025"},{"key":"4097_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.comptc.2021.113329","volume":"1203","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Cheng X, Nie K et al (2021) Structures, relative stability, bond dissociation energies, and stabilization energies of alkynes and imines from a homodesmotic reaction. Comput Theor Chem 1203:113329. https:\/\/doi.org\/10.1016\/j.comptc.2021.113329","journal-title":"Comput Theor Chem"},{"issue":"4","key":"4097_CR52","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/ajoc.201200103","volume":"1","author":"L-G Zhuo","year":"2012","unstructured":"Zhuo L-G, Liao W, Yu Z-X (2012) A Frontier molecular orbital theory approach to understanding the Mayr equation and to quantifying nucleophilicity and electrophilicity by using HOMO and LUMO energies. Asian J Org Chem 1(4):336\u2013345. https:\/\/doi.org\/10.1002\/ajoc.201200103","journal-title":"Asian J Org Chem"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04097-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04097-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04097-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:31:20Z","timestamp":1758540680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04097-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4097"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04097-x","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}